Geno recently announced the results of a study demonstrating the ketogenic effects of its exogenous ketone ingredient, Avelo 1,3-butanediol.
Geno (San Diego, CA) recently announced the results of a study1 demonstrating the ketogenic effects of its exogenous ketone ingredient, Avela 1,3-butanediol. In the open-label study, 26 healthy adults following a 12 hour overnight fast consumed one beverage containing 11.5 g of 1,3-butanediol at baseline, 30, and 60 minutes for a total intake of 34.5 g. Researchers assessed blood beta-hydroxybutyrate (BHB) levels, GI tolerability, and sleepiness at baseline, 30, 60, 90, 120, 180, 240, and 300 minutes. Additionally, subjects consumed a protein bar at 240 minutes.
Results showed that BHB levels increased significantly at each time point relative to baseline with females experiencing a significantly greater time to maximal concentration, and incremental area under the curve of BHB than males. The ingredient was also found to have no impact on sleepiness and was well tolerated.
BHB is a ketone which 1,3-butanediol can convert into. According to Geno’s press release, elevated levels of BHB have been reported in scientific literature to offer benefits such as increased energy, mental clarity, and improved athletic endurance.
“In this study, Avela demonstrated good tolerability when taken in accordance with GRAS guidelines,” said James Lowder, MD, hemotologist oncologist, and the study’s principal investigator, in a press release. “The results tell us we can consider 1,3-Butanediol effective at producing blood ketone levels comparable to those achieved through the diet alone.”
"Over the last ten years, scientists and consumers have realized that ketones are more than an emergency backup fuel,” added Brianna Stubbs, DPhil, lead translational scientist for The Buck Institute for Research on Aging. “They are discovering the different effects ketones can have within the body. This is an energizing, exciting moment and a step forward for the industry.”
Avela was launched in the U.S. in November of 2022 and has an independent conclusion of GRAS (generally recognized as safe) for use as a source of energy in beverages, bars, and gels.
Reference
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.